BALVERSA
NDC 59676-040, Erdafitinib, tablet, film coated, from Janssen Products LP.
- Product NDC
- 59676-040
- Status
- Listed
- Labeler
- Janssen Products LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59676-040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERDAFITINIB4 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Fibroblast Growth Factor Receptor Inhibitors [MoA]; Kinase Inhibitor [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59676-040-28 | 59676004028 | 1 BOTTLE in 1 CARTON (59676-040-28) / 28 TABLET, FILM COATED in 1 BOTTLE |
| 59676-040-56 | 59676004056 | 1 BOTTLE in 1 CARTON (59676-040-56) / 56 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee
Use it
Look up 59676-040 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59676-040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59676-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.